Cargando…
CD146 is a Novel ANGPTL2 Receptor that Promotes Obesity by Manipulating Lipid Metabolism and Energy Expenditure
Obesity and its related complications pose an increasing threat to human health; however, targetable obesity‐related membrane receptors are not yet elucidated. Here, the membrane receptor CD146 is demonstrated to play an essential role in obesity. In particular, CD146 acts as a new adipose receptor...
Autores principales: | Wu, Zhenzhen, Liu, Jingyu, Chen, Gang, Du, Junfeng, Cai, Huiyun, Chen, Xuehui, Ye, Gaoqi, Luo, Yongting, Luo, Yiyi, Zhang, Liwen, Duan, Hongxia, Liu, Zheng, Yang, Sai, Sun, Hongwei, Cui, Yan, Sun, Lei, Zhang, Hongjie, Shi, Guizhi, Wei, Taotao, Liu, Pingsheng, Yan, Xiyun, Feng, Jing, Bu, Pengcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967059/ https://www.ncbi.nlm.nih.gov/pubmed/33747748 http://dx.doi.org/10.1002/advs.202004032 |
Ejemplares similares
-
Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis
por: Luo, Yongting, et al.
Publicado: (2017) -
CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis
por: Yan, Huiwen, et al.
Publicado: (2017) -
CD146 Associates with Gp130 to Control a Macrophage Pro‐inflammatory Program That Regulates the Metabolic Response to Obesity
por: Duan, Hongxia, et al.
Publicado: (2022) -
CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension
por: Luo, Yongting, et al.
Publicado: (2019) -
Publisher Correction: CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension
por: Luo, Yongting, et al.
Publicado: (2019)